Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Expression of microRNA-31 and its clinicopathologic significance in oral squamous cell carcinoma].

Ouyang SB, Wang J, Huang ZK, Liao L.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2013 Aug;48(8):481-4. Chinese.

PMID:
24238414
2.

[Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].

Liu YM, Huang JH, Feng DY, Guo XC.

Ai Zheng. 2005 Nov;24(11):1354-7. Chinese.

PMID:
16552962
3.

Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.

Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R, Gilbert RW, Gullane PJ, Irish JC, Kamel-Reid S.

Mol Cancer. 2010 Sep 10;9:238. doi: 10.1186/1476-4598-9-238.

4.

Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.

Ni YH, Huang XF, Wang ZY, Han W, Deng RZ, Mou YB, Ding L, Hou YY, Hu QG.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):227-33. doi: 10.1016/j.oooo.2013.10.017.

PMID:
24439918
5.

DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.

Hamada T, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K.

Cancer. 2012 Nov 1;118(21):5251-64. doi: 10.1002/cncr.27542.

6.

Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.

Zhang L, Pan HY, Zhong LP, Wei KJ, Yang X, Li J, Shen GF, Zhang Z.

J Oral Pathol Med. 2010 Jul;39(6):470-6. doi: 10.1111/j.1600-0714.2009.00869.x.

PMID:
20149058
7.
8.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
9.

[Expression and significance of angiopoietin-1 and angiopoietin-2 in oral squamous cell cacinoma].

Li C, Feng HC, Chen JC, Song YF.

Ai Zheng. 2005 Nov;24(11):1388-93. Chinese.

PMID:
16552969
10.
11.

Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.

Kono M, Watanabe M, Abukawa H, Hasegawa O, Satomi T, Chikazu D.

J Oral Maxillofac Surg. 2013 Oct;71(10):1694-702. doi: 10.1016/j.joms.2013.04.015.

PMID:
23809761
12.

[Functional significance of TGF-beta1 signal transduction pathway in oral squamous cell carcinoma].

Wang XM, Liu CM, Zhang CR, Xu XG, Fu SB.

Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):28-32. Chinese.

PMID:
19538865
13.

Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.

Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP.

Int J Oral Maxillofac Surg. 2008 Apr;37(4):372-8. doi: 10.1016/j.ijom.2007.11.021.

PMID:
18295452
14.

[Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].

Zhang J, Zeng Y, Zheng J, Xu J.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2013 Dec;48(12):752-4. Chinese.

PMID:
24495728
15.

[Investigation of CXCR4 in oral squamous cell carcinoma and its influence on proliferation of tumor cells in vitro].

Xu M, Li WY, Chen XM, Wang XH, Huang J, Wang L.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2006 Jun;41(6):372-5. Chinese.

PMID:
16836911
16.

USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.

Piao S, Liu Y, Hu J, Guo F, Ma J, Sun Y, Zhang B.

PLoS One. 2012;7(8):e42540. doi: 10.1371/journal.pone.0042540.

17.

Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.

Gao ZB, Duan YQ, Zhang L, Chen DW, Ding PT.

Int J Mol Med. 2005 Oct;16(4):599-603.

PMID:
16142392
18.

Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.

Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC.

Oral Dis. 2010 May;16(4):360-4. doi: 10.1111/j.1601-0825.2009.01646.x.

PMID:
20233326
19.

Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma.

Jiang Q, Patima S, Ye DX, Pan HY, Zhang P, Zhang ZY.

Oncol Rep. 2012 Apr;27(4):1058-64. doi: 10.3892/or.2011.1613.

20.

Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.

Fu TY, Hsieh IC, Cheng JT, Tsai MH, Hou YY, Lee JH, Liou HH, Huang SF, Chen HC, Yen LM, Tseng HH, Ger LP.

J Oral Pathol Med. 2016 Feb;45(2):89-95. doi: 10.1111/jop.12335.

PMID:
26211876
Items per page

Supplemental Content

Support Center